Need, potential for Hepatitis C vaccine highlighted by Hopkins study

"Our findings suggest that humans can acquire immunity that protects against the disease caused by hepatitis C virus."

Humans may be able to develop immunity to hepatitis C virus, according to a study by Hopkins researchers published in the April 26 issue of The Lancet, findings that add to a growing body of evidence that immunity to the virus can be acquired. The findings are important because no vaccines exist for preventing hepatitis C in humans although preliminary vaccine research in primates appears promising.

Other studies in chimpanzees demonstrate that although animals who were previously infected or vaccinated could be infected with hepatitis C virus, those infections were less likely to persist compared to animals infected for the first time, according to David L. Thomas, associate professor of medicine at Hopkins and lead author of the study.

"We found the same in humans, suggesting that humans can acquire immunity that protects against hepatitis C virus persistence," says Thomas. "If this is indeed the case, it suggests that vaccines can be used to protect us from the long-term complications of hepatitis C infection, like liver cirrhosis and liver cancer."

In their study of injecting drug users from Baltimore, Md., Thomas, co-author Shruti Mehta, M.P.H., and colleagues identified 164 people whose blood tests revealed no evidence of previous hepatitis C infection, and 98 people who had been infected in the past but were not currently infected with the virus. They compared the incidence and persistence of infection in these two groups over four consecutive six-month periods.

People previously infected were half as likely to develop new infections compared to those who had not been previously infected (12% compared to 21%, respectively). Among HIV-1-negative people, those previously infected were 12 times less likely to develop persistent infection than people infected for the first time .

"The medical

Contact: Trent Stockton
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Award winning researchers reveal potential new role for Glivec
2. Evidence builds for potential new cancer drug target
3. Scientists discover potential new way to control drug-resistant bacteria
4. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
5. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
6. Managing occupational exposures to potential bioterrorist agents
7. Location of potential familial lung cancer gene discovered
8. Acamprosate: potential medication for treating alcoholism
9. Common chemicals morphing into potential toxins in Arctic
10. Yale researchers discover new potential asthma therapeutic targets related to parasites and insects
11. Researchers identify two potential protein targets for new drug therapies for pancreatic cancer

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: